Clinical Trials Browser

Interventional × HER2 Positive Breast Cancer × Lapatinib × Clear all

NCT02362958 2020-07-15

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Phase 2 Completed

HER2 Positive Breast Cancer